Aegerion CEO on Cholesterol Drug Lomitapide

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Rio Tinto to Buy Back Bonds to Reduce Debt
42:19 - Rio Tinto Group, the world’s second-largest mining company, offered to buy back as much as $2.5 billion of its bonds as part of a new plan to reduce its debt. Bloomberg's Paul Allen reports on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
  • U.K. Police Say 'a Number' of Concert Goers Killed
  • CrowdStrike CEO Weighs in on Ransomware Attacks
  • President Trump to Submit Budget Request